Chemotherapy for Neuroendocrine Tumours: When and Which Regimens?

14 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Discover when chemotherapy is recommended for neuroendocrine tumours (NETs), focusing on progressive pancreatic NETs, grade 3 neoplasms, and poorly differentiated carcinomas. Explore key regimens like streptozocin-based, temozolomide-capecitabine, and platinum-etoposide, backed by trials such as ECOG-ACRIN E2211 and ENETS guidelines. Learn response rates, side effects, and patient actions for better outcomes in higher-grade NETs.

This content is entirely based on medical research and evidence, carefully curated by Mr Saboor Khan PhD FRCS FACS (Consultant Surgeon).

Timestamps:
00:00 Introduction
01:00 What is Chemotherapy for NETs?
01:45 Higher-Grade Pancreatic NETs Indication
03:00 Streptozocin-Based Regimens
04:30 Temozolomide-Capecitabine Alternative
06:00 Platinum-Etoposide for NECs
07:30 Response Rate Expectations
08:30 Action Steps and Discussions
09:30 Conclusion and Resources

Explore the full video series in the playlist for a broader understanding of your condition with evidence-based content.

Educational Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice. Personal medical decisions must be made in consultation with your treating healthcare team. Patients should not draw inferences about their own condition from this content. Every effort has been made to ensure the information is current at the time of production; however, this cannot be guaranteed.
Categoria
Oncology
Commenta per primo questo video.

Prossimo